世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000028591

世界のHIV診断薬市場調査レポート‐2027年までの予測

Market Research Future

Global HIV Diagnostics Market Research Report – Forecast till 2027

発刊日 2020/12

言語英語

体裁PDF/140ページ

「PDF」版140ページ

0000028591

世界のHIV診断薬市場調査レポート‐2027年までの予測
Global HIV Diagnostics Market Research Report – Forecast till 2027

4,450 USD

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

世界のHIV診断薬市場調査レポート:製品別(消耗品、機器、ソフトウェア&サービス)、検査の種類別(抗体検査、ウイルス量検査、CD4検査、乳児早期診断検査、ウイルス同定検査)、エンドユーザー別(診断検査センター、病院、血液バンク、在宅医療&その他)、地域別(北米、ヨーロッパ、アジア太平洋、中東&アフリカ)−2027年までの予測

市場予測

世界のHIV診断市場は2027年までに訳71億1,826万ドルに達し、2020年から2027年までのCAGRは10.6%と予想されます。

市場概要

HIVは他の自己免疫疾患と同様に免疫システムに影響を及ぼす自己免疫疾患であり、患者は他の疾患や感染症に罹りやすくなります。HIV診断薬は主にHIV検査に使用されます。この市場はSiemens Healthiness、Roche Diagnostics、Abbott Laboratories、Beckman Coulter, Inc.をはじめ、その他多くのメーカーが占有しています。これらのメーカーは新製品や新規技術の発売、戦略的提携に取り組んでいます。例えば、2019年1月にはHologic Inc.が一般的な性感染症(STI)の発見に使用されるAptima® マイコプラズマ ジェニタリウムAssayに対してFDAの承認を得ました。

レポート詳細

目次

Table of Contents

1. EXECUTIVE SUMMARY
1.1. Market Attractiveness Analysis
1.1.1. Global HIV Diagnostics Market, by Product
1.1.2. Global HIV Diagnostics Market, by Test Type
1.1.3. Global HIV Diagnostics Market, by End User

2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Breakdown of Primary Respondents
3.5. Forecasting Test Types
3.6. Research Methodology for Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.2.1. R&D and Designing
5.2.2. Manufacturing
5.2.3. Distribution & Sales
5.2.4. Post Sales Services
5.3. Impact of COVID 19 on HIV Diagnostics Market
5.3.1. Impact on Market Value in 2020 and 2021
5.3.2. Clinical Trial Impact
5.3.3. Impact of Demand
5.3.4. Strategies to Overcome the challenges

6. GLOBAL HIV DIAGNOSTICS MARKET, BY PRODUCT
6.1. Overview
6.2. Consumables
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.2.1. Assays and Kits & Reagents
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.2.2. Other Consumables
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3. Instruments
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.4. Software & Services
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027

7. GLOBAL HIV DIAGNOSTICS MARKET, BY TEST TYPE
7.1. Overview
7.2. Antibody Tests
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.2.1. HIV-1 Screening Test
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.2.1.1. Elisa
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.2.1.2. Rapid Tests
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.2.1.3. Home Access Dried Blood Spots
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.2.2. HIV-1 Antibody Confirmatory Tests
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.2.2.1. Western Blot Tests
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.2.2.2. Indirect Immunofluorescence Assays (IFA)
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.2.2.3. Line Immunoassay
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.2.2.4. Radio-Immunoprecipitation Assays
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.2.3. HIV-2 & Group O Diagnostic Tests
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3. Viral Load Tests
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.4. CD4 Tests
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.5. Tests for Early Infant Diagnosis
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.6. Tests for Viral Identification
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027

8. GLOBAL HIV DIAGNOSTICS MARKET, BY END USER
8.1. Overview
8.2. Diagnostic Laboratories
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.3. Hospitals
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.4. Blood Banks
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.5. Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027

9. GLOBAL HIV DIAGNOSTICS MARKET, BY REGION
9.1. Overview
9.2. Americas
9.2.1. North America
9.2.1.1. US
9.2.1.2. Canada
9.2.2. Latin America
9.3. Europe
9.3.1. Western Europe
9.3.1.1. Germany
9.3.1.2. France
9.3.1.3. Italy
9.3.1.4. Spain
9.3.1.5. UK
9.3.1.6. Rest of Western Europe
9.3.2. Eastern Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest of Asia-Pacific
9.5. Middle East & Africa
9.5.1. Middle East
9.5.2. Africa

10. COMPANY LANDSCAPE
10.1. Overview
10.2. Competitor Dashboard
10.3. Major Growth Strategy in the Global HIV Diagnostics Market
10.4. Competitive Benchmarking
10.5. The Leading Player in terms of Number of Developments in the Global HIV Diagnostics Market
10.6. Key Developments & Growth Strategies
10.6.1. New Product Launch/Service Deployment
10.6.2. Merger & Acquisition
10.6.3. Joint Ventures
10.7. Major Players Financial Matrix & Market Ratio
10.7.1. Sales & Operating Income 2019
10.7.2. Major Players R&D Expenditure 2019

11. COMPANY PROFILES
11.1. Siemens Healthineers (A Division of Siemens AG)
11.1.1. Company Overview
11.1.2. Products/Services Offered
11.1.3. Financial Overview
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Roche Diagnostics (Division of Hoffman La Roche Ltd.)
11.3. Abbott Laboratories
11.4. Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
11.5. Thermo-Fisher Scientific Inc.
11.6. Merck KGaA
11.7. Becton, Dickinson & Company
11.8. Hologic Inc.
11.9. Alere Inc.
11.10. Bio-Rad Laboratories
11.11. Others

12. APPENDIX
12.1. References
12.2. Related Reports
NOTE:
This table of content is tentative and subject to change as the research progresses.
・ In section 11, only the top companies will be profiled. Each company will be profiled based on the Market Overview, Financials, Product Portfolio, Business Strategies, and Recent Developments parameters.
・ Please note: The financial details of the company cannot be provided if the information is not available in the public domain and or from reliable sources.

LIST OF TABLES
TABLE 1 GLOBAL HIV DIAGNOSTICS MARKET SYNOPSIS, 2017-2027
TABLE 2 GLOBAL HIV DIAGNOSTICS MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)
TABLE 3 GLOBAL HIV DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 4 GLOBAL HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
TABLE 5 GLOBAL HIV DIAGNOSTICS MARKET, BY END USERS, 2020-2027 (USD MILLION)
TABLE 6 GLOBAL HIV DIAGNOSTICS MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 7 NORTH AMERICA: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 8 NORTH AMERICA: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
TABLE 9 NORTH AMERICA: HIV DIAGNOSTICS MARKET, BY END USERS, 2020-2027 (USD MILLION)
TABLE 10 US: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 11 US: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
TABLE 12 US: HIV DIAGNOSTICS MARKET, BY END USERS, 2020-2027 (USD MILLION)
TABLE 13 CANADA: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 14 CANADA: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
TABLE 15 CANADA: HIV DIAGNOSTICS MARKET, BY END USERS, 2020-2027 (USD MILLION)
TABLE 16 LATIN AMERICA: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 17 LATIN AMERICA: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
TABLE 18 LATIN AMERICA: HIV DIAGNOSTICS MARKET, BY END USERS, 2020-2027 (USD MILLION)
TABLE 19 EUROPE: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 20 EUROPE: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
TABLE 21 EUROPE: HIV DIAGNOSTICS MARKET, BY END USERS, 2020-2027 (USD MILLION)
TABLE 22 WESTERN EUROPE: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 23 WESTERN EUROPE: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
TABLE 24 WESTERN EUROPE: HIV DIAGNOSTICS MARKET, BY END USERS, 2020-2027 (USD MILLION)
TABLE 25 EASTERN EUROPE: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 26 EASTERN EUROPE: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
TABLE 27 EASTERN EUROPE: HIV DIAGNOSTICS MARKET, BY END USERS, 2020-2027 (USD MILLION)
TABLE 28 ASIA-PACIFIC: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 29 ASIA-PACIFIC: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
TABLE 30 ASIA-PACIFIC: HIV DIAGNOSTICS MARKET, BY END USERS, 2020-2027 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA: HIV DIAGNOSTICS MARKET, BY END USERS, 2020-2027 (USD MILLION)

LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL HIV DIAGNOSTICS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL HIV DIAGNOSTICS MARKET
FIGURE 4 GLOBAL HIV DIAGNOSTICS MARKET SHARE, BY PRODUCT, 2019 (%)
FIGURE 5 GLOBAL HIV DIAGNOSTICS MARKET SHARE, BY TEST TYPE, 2019 (%)
FIGURE 6 GLOBAL HIV DIAGNOSTICS MARKET SHARE, BY END USERS, 2019 (%)
FIGURE 7 GLOBAL HIV DIAGNOSTICS MARKET SHARE, BY REGION, 2019 (%)
FIGURE 8 AMERICAS: HIV DIAGNOSTICS MARKET SHARE BY REGION, 2019 (%)
FIGURE 9 NORTH AMERICA: HIV DIAGNOSTICS MARKET SHARE, BY COUNTRY, 2019 (%)
FIGURE 10 EUROPE: HIV DIAGNOSTICS MARKET SHARE, BY REGION, 2019 (%)
FIGURE 11 WESTERN EUROPE: HIV DIAGNOSTICS MARKET SHARE, BY COUNTRY, 2019 (%)
FIGURE 12 ASIA-PACIFIC: HIV DIAGNOSTICS MARKET SHARE, BY COUNTRY, 2019 (%)
FIGURE 13 MIDDLE EAST & AFRICA: HIV DIAGNOSTICS MARKET SHARE, BY COUNTRY, 2019 (%)
FIGURE 14 GLOBAL HIV DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS, 2019 (%)
FIGURE 15 SIEMENS HEALTHINEERS (A DIVISION OF SIEMENS AG): KEY FINANCIALS
FIGURE 16 SIEMENS HEALTHINEERS (A DIVISION OF SIEMENS AG): SEGMENTAL REVENUE
FIGURE 17 SIEMENS HEALTHINEERS (A DIVISION OF SIEMENS AG): REGIONAL REVENUE
FIGURE 18 ROCHE DIAGNOSTICS (DIVISION OF HOFFMAN LA ROCHE LTD.): KEY FINANCIALS
FIGURE 19 ROCHE DIAGNOSTICS (DIVISION OF HOFFMAN LA ROCHE LTD.).: SEGMENTAL REVENUE
FIGURE 20 ROCHE DIAGNOSTICS (DIVISION OF HOFFMAN LA ROCHE LTD.): REGIONAL REVENUE
FIGURE 21 ABBOTT LABORATORIES: KEY FINANCIALS
FIGURE 22 ABBOTT LABORATORIES: SEGMENTAL REVENUE
FIGURE 23 ABBOTT LABORATORIES: REGIONAL REVENUE
FIGURE 24 BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER CORPORATION): KEY FINANCIALS
FIGURE 25 BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER CORPORATION): SEGMENTAL REVENUE
FIGURE 26 BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER CORPORATION): REGIONAL REVENUE
FIGURE 27 THERMO-FISHER SCIENTIFIC INC.: KEY FINANCIALS
FIGURE 28 THERMO-FISHER SCIENTIFIC INC.: SEGMENTAL REVENUE
FIGURE 29 THERMO-FISHER SCIENTIFIC INC.: REGIONAL REVENUE
FIGURE 30 MERCK KGAA: KEY FINANCIALS
FIGURE 31 MERCK KGAA: SEGMENTAL REVENUE
FIGURE 32 MERCK KGAA: REGIONAL REVENUE
FIGURE 33 BECTON, DICKINSON & COMPANY: KEY FINANCIALS
FIGURE 34 BECTON, DICKINSON & COMPANY: SEGMENTAL REVENUE
FIGURE 35 BECTON, DICKINSON & COMPANY: REGIONAL REVENUE
FIGURE 36 HOLOGIC INC.: KEY FINANCIALS
FIGURE 37 HOLOGIC INC.: SEGMENTAL REVENUE
FIGURE 38 HOLOGIC INC.: REGIONAL REVENUE
FIGURE 39 ALERE INC.: KEY FINANCIALS
FIGURE 40 ALERE INC.: SEGMENTAL REVENUE
FIGURE 41 ALERE INC.: REGIONAL REVENUE
FIGURE 42 BIO-RAD LABORATORIES.: KEY FINANCIALS
FIGURE 43 BIO-RAD LABORATORIES.: SEGMENTAL REVENUE
FIGURE 44 BIO-RAD LABORATORIES.: REGIONAL REVENUE

この商品のレポートナンバー

0000028591

TOP